J&J's single vaccine shot can protect from delta variant!!!
According to Johnson & Johnson, its single-shot Covid-19 vaccination generates a robust response against the Delta form of the virus. The vaccination generates neutralising antibody activity throughout the period of at least eight months against every variation, including Delta, which first discovered in India, according to a study of samples taken obtained from eight vaccinated persons.
"Today's newly disclosed studies have confirmed the Johnson & Johnson Covid-19 vaccine's potential to help safeguard people's health throughout the world," Said the company MD Paul Stoffels. The single-dose vaccination, according to the firm, was 85 per cent effective toward severe or critical illness and protected against hospitalisation and death. According to J&J, the second dosage of their vaccine has been shown to boost a person's antibody level. At the end of August, the firm intends to provide effectiveness data from an early trial of the two-shot regimen.
Within 29 days of the first dosage, the injection had neutralised the delta version, and immunity had developed and increased over time. It further said that the effectiveness was similar across all locations investigated internationally, including brazil and South Africa, where fast-developing Beta and Zeta variants were prevalent throughout the research period. Last week, the firm stated that it is in negotiations with the indian government to see how it might speed up the supply of its vaccination to the country.
"Today's newly disclosed studies have confirmed the Johnson & Johnson Covid-19 vaccine's potential to help safeguard people's health throughout the world," Said the company MD Paul Stoffels. The single-dose vaccination, according to the firm, was 85 per cent effective toward severe or critical illness and protected against hospitalisation and death. According to J&J, the second dosage of their vaccine has been shown to boost a person's antibody level. At the end of August, the firm intends to provide effectiveness data from an early trial of the two-shot regimen.
Within 29 days of the first dosage, the injection had neutralised the delta version, and immunity had developed and increased over time. It further said that the effectiveness was similar across all locations investigated internationally, including brazil and South Africa, where fast-developing Beta and Zeta variants were prevalent throughout the research period. Last week, the firm stated that it is in negotiations with the indian government to see how it might speed up the supply of its vaccination to the country.